FDA Inspection 1274311 — Dr. Pablo Forte Soto MD, MSc, DPhil
The FDA completed an inspection of Dr. Pablo Forte Soto MD, MSc, DPhil on May 2, 2025 in Harrow. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 2, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Harrow (United Kingdom)
Additional Details
Clinical BA/BE